Neoadjuvant tamoxifen and aromatase inhibitors: comparisons and clinical outcomes
- 1 September 2003
- journal article
- research article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 86 (3-5) , 295-299
- https://doi.org/10.1016/s0960-0760(03)00370-4
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Neoadjuvant endocrine therapy of breast cancer: a surgical perspectiveEuropean Journal Of Cancer, 2002
- Epidemiological Basis of Hormonal Chemoprevention of Breast CancerPublished by Taylor & Francis ,2002
- Breast conservative surgery: is it appropriate for locally advanced breast cancer following downstaging by neoadjuvant chemotherapy. A pathological assessmentThe Breast, 1999
- Conservation Surgery After Primary Chemotherapy in Large Carcinomas of the BreastAnnals of Surgery, 1995
- Treatment of breast cancer in elderly patientsJournal of Surgical Oncology, 1995
- Should surgery remain the initial treatment of “operable” breast cancer?European Journal of Cancer and Clinical Oncology, 1991
- Breast cancer in elderly women: A Cancer Research Campaign trial comparing treatment with tamoxifen and optimal surgery with tamoxifen aloneBritish Journal of Surgery, 1991
- Primary Chemotherapy To Avoid Mastectomy in Tumors With Diameters of Three Centimeters or MoreJNCI Journal of the National Cancer Institute, 1990
- Preoperative chemotherapy followed by mastectomy for locally advanced breast cancerJournal of Surgical Oncology, 1983
- Chemotherapy Before and After Mastectomy in Stage III Breast CancerArchives of Surgery, 1982